Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
Autor(a) principal: | |
---|---|
Data de Publicação: | 2002 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNIFESP |
dARK ID: | ark:/48912/001300000b36f |
DOI: | 10.1590/S0100-879X2002000400010 |
Texto Completo: | http://dx.doi.org/10.1590/S0100-879X2002000400010 http://repositorio.unifesp.br/handle/11600/1411 |
Resumo: | Venlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions. |
id |
UFSP_6ed3baf91c4130a75f06212d7471aa77 |
---|---|
oai_identifier_str |
oai:repositorio.unifesp.br/:11600/1411 |
network_acronym_str |
UFSP |
network_name_str |
Repositório Institucional da UNIFESP |
repository_id_str |
3465 |
spelling |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive ratsAntidepressantVenlafaxineConvulsionEpilepsyPentylenetetrazoleVenlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de PsicobiologiaUniversidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de MorfofisiologiaUNIFESP, EPM, Depto. de PsicobiologiaSciELOAssociação Brasileira de Divulgação CientíficaUniversidade Federal de São Paulo (UNIFESP)Universidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de MorfofisiologiaSantos-Junior, Jair Guilherme [UNIFESP]Do Monte, F.h.m.Russi, M.Agustine, P.e.Lanziotti, Vanusa Maria Nascimento Bispo2015-06-14T13:29:40Z2015-06-14T13:29:40Z2002-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion469-472application/pdfhttp://dx.doi.org/10.1590/S0100-879X2002000400010Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002.10.1590/S0100-879X2002000400010S0100-879X2002000400010.pdf0100-879XS0100-879X2002000400010http://repositorio.unifesp.br/handle/11600/1411WOS:000175259700010ark:/48912/001300000b36fengBrazilian Journal of Medical and Biological Researchinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-07-29T17:37:50Zoai:repositorio.unifesp.br/:11600/1411Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-12-11T20:08:28.936427Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false |
dc.title.none.fl_str_mv |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
title |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
spellingShingle |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats Santos-Junior, Jair Guilherme [UNIFESP] Antidepressant Venlafaxine Convulsion Epilepsy Pentylenetetrazole Santos-Junior, Jair Guilherme [UNIFESP] Antidepressant Venlafaxine Convulsion Epilepsy Pentylenetetrazole |
title_short |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
title_full |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
title_fullStr |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
title_full_unstemmed |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
title_sort |
Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats |
author |
Santos-Junior, Jair Guilherme [UNIFESP] |
author_facet |
Santos-Junior, Jair Guilherme [UNIFESP] Santos-Junior, Jair Guilherme [UNIFESP] Do Monte, F.h.m. Russi, M. Agustine, P.e. Lanziotti, Vanusa Maria Nascimento Bispo Do Monte, F.h.m. Russi, M. Agustine, P.e. Lanziotti, Vanusa Maria Nascimento Bispo |
author_role |
author |
author2 |
Do Monte, F.h.m. Russi, M. Agustine, P.e. Lanziotti, Vanusa Maria Nascimento Bispo |
author2_role |
author author author author |
dc.contributor.none.fl_str_mv |
Universidade Federal de São Paulo (UNIFESP) Universidade do Estado de Santa Catarina Centro de Ciências Agroveterinárias Departamento de Morfofisiologia |
dc.contributor.author.fl_str_mv |
Santos-Junior, Jair Guilherme [UNIFESP] Do Monte, F.h.m. Russi, M. Agustine, P.e. Lanziotti, Vanusa Maria Nascimento Bispo |
dc.subject.por.fl_str_mv |
Antidepressant Venlafaxine Convulsion Epilepsy Pentylenetetrazole |
topic |
Antidepressant Venlafaxine Convulsion Epilepsy Pentylenetetrazole |
description |
Venlafaxine, an atypical antidepressant drug, has been used to treat several neurological disorders, presenting excellent efficacy and tolerability. Clinical seizures after venlafaxine treatment have occasionally been reported when the drug was used at very high doses or in combination with other medications. The aim of the present study was to investigate the convulsant effects of venlafaxine in rats under controlled laboratory conditions. Adult male Wistar rats (8 per group) receiving venlafaxine or saline at the doses of 25-150 mg/kg were subjected 30 min later to injections of pentylenetetrazole at the dose of 60 mg/kg. The animals receiving 75, 100 and 150 mg/kg venlafaxine presented increased severity of convulsion when compared to controls (P = 0.02, P = 0.04, and P = 0.0004, respectively). Indeed, an increased percentage of death was observed in these groups (50, 38, and 88%, respectively) when compared to the percentage of death in the controls (0%). The group receiving 150 mg/kg showed an reduction in death latency (999 ± 146 s) compared to controls (1800 ± 0 s; cut-off time). Indeed, in this group, all animals developed seizures prior to pentylenetetrazole administration. Surprisingly, the groups receiving venlafaxine at the doses of 25 and 50 mg/kg showed a tendency towards an increase in the latency to the first convulsion. These findings suggest that venlafaxine at doses of 25 and 50 mg/kg has some tendency to an anticonvulsant effect in the rat, whereas doses of 75, 100 and 150 mg/kg presented clear proconvulsant effects in rats submitted to the pentylenetetrazole injection. These findings are the first report in the literature concerning the role of venlafaxine in seizure genesis in the rat under controlled conditions. |
publishDate |
2002 |
dc.date.none.fl_str_mv |
2002-04-01 2015-06-14T13:29:40Z 2015-06-14T13:29:40Z |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1590/S0100-879X2002000400010 Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002. 10.1590/S0100-879X2002000400010 S0100-879X2002000400010.pdf 0100-879X S0100-879X2002000400010 http://repositorio.unifesp.br/handle/11600/1411 WOS:000175259700010 |
dc.identifier.dark.fl_str_mv |
ark:/48912/001300000b36f |
url |
http://dx.doi.org/10.1590/S0100-879X2002000400010 http://repositorio.unifesp.br/handle/11600/1411 |
identifier_str_mv |
Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 4, p. 469-472, 2002. 10.1590/S0100-879X2002000400010 S0100-879X2002000400010.pdf 0100-879X S0100-879X2002000400010 WOS:000175259700010 ark:/48912/001300000b36f |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Brazilian Journal of Medical and Biological Research |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
469-472 application/pdf |
dc.publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
publisher.none.fl_str_mv |
Associação Brasileira de Divulgação Científica |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UNIFESP instname:Universidade Federal de São Paulo (UNIFESP) instacron:UNIFESP |
instname_str |
Universidade Federal de São Paulo (UNIFESP) |
instacron_str |
UNIFESP |
institution |
UNIFESP |
reponame_str |
Repositório Institucional da UNIFESP |
collection |
Repositório Institucional da UNIFESP |
repository.name.fl_str_mv |
Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP) |
repository.mail.fl_str_mv |
biblioteca.csp@unifesp.br |
_version_ |
1822219216747495424 |
dc.identifier.doi.none.fl_str_mv |
10.1590/S0100-879X2002000400010 |